Compare ILMN & PRU Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
Current Price
| Metric | ILMN | PRU |
|---|---|---|
| Founded | 1998 | 1875 |
| Country | United States | United States |
| Employees | N/A | N/A |
| Industry | Medical Specialities | Life Insurance |
| Sector | Health Care | Finance |
| Exchange | Nasdaq | Nasdaq |
| Market Cap | 37.0B | 39.0B |
| IPO Year | 2000 | 2001 |
| Metric | ILMN | PRU |
|---|---|---|
| Price | $262.77 | $115.99 |
| Analyst Decision | Buy | Hold |
| Analyst Count | 21 | 18 |
| Target Price | ★ $241.05 | $111.07 |
| AVG Volume (30 Days) | ★ 2.6M | 1.4M |
| Earning Date | 10-29-2026 | 11-03-2026 |
| Dividend Yield | N/A | ★ 4.83% |
| EPS Growth | ★ 170.87 | 33.20 |
| EPS | 2.22 | ★ 4.48 |
| Revenue | $4,343,000,000.00 | ★ $60,774,000,000.00 |
| Revenue This Year | $6.48 | N/A |
| Revenue Next Year | $6.46 | $1.69 |
| P/E Ratio | $118.04 | ★ $25.88 |
| Revenue Growth | ★ N/A | N/A |
| 52 Week Low | $94.00 | $91.89 |
| 52 Week High | $309.35 | $127.72 |
| Indicator | ILMN | PRU |
|---|---|---|
| Relative Strength Index (RSI) | 53.09 | 50.97 |
| Support Level | $254.00 | $111.04 |
| Resistance Level | $309.35 | $119.76 |
| Average True Range (ATR) | 14.27 | 1.95 |
| MACD | -3.01 | 0.37 |
| Stochastic Oscillator | 14.89 | 83.72 |
Illumina provides tools and services to analyze genetic material with life science and clinical lab applications. The company generates over 90% of its revenue from sequencing instruments, consumables, and services. Illumina's high-throughput technology enables whole genome sequencing in humans and other large organisms. Its lower throughput tools enable applications that require smaller data outputs, such as viral and cancer tumor screening. Illumina also sells microarrays that enable lower-cost, focused genetic screening with primarily consumer and agricultural applications.
Prudential Financial is one of the largest US life insurers, offering annuities, life insurance, and asset-management products. The United States and Japan are its two largest markets. Its US business contributed about 50% of adjusted 2025 earnings and includes institutional retirement (mostly pension risk transfer), individual retirement (annuities), group insurance, and individual life insurance. Its international business represented about 39% of adjusted earnings, with a strong market position in Japan, and the firm also has a presence in emerging markets like Brazil. The company's investment management business, PGIM, contributed approximately 11% of its 2025 adjusted earnings. PGIM had around $1.47 trillion in assets under management at the end of fourth-quarter 2025.